<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Fam Pract</journal-id><journal-id journal-id-type="iso-abbrev">Fam Pract</journal-id><journal-id journal-id-type="pmc-domain-id">734</journal-id><journal-id journal-id-type="pmc-domain">fampract</journal-id><journal-id journal-id-type="publisher-id">famprj</journal-id><journal-title-group><journal-title>Family Practice</journal-title></journal-title-group><issn pub-type="ppub">0263-2136</issn><issn pub-type="epub">1460-2229</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11636625</article-id><article-id pub-id-type="pmcid-ver">PMC11636625.1</article-id><article-id pub-id-type="pmcaid">11636625</article-id><article-id pub-id-type="pmcaiid">11636625</article-id><article-id pub-id-type="pmid">38052095</article-id><article-id pub-id-type="doi">10.1093/fampra/cmad112</article-id><article-id pub-id-type="publisher-id">cmad112</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Epidemiology</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00780</subject></subj-group></article-categories><title-group><article-title>The long-term impacts of opioid use before and after joint arthroplasty: matched cohort analysis of New Zealand linked register data</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0259-1217</contrib-id><name name-style="western"><surname>Pryymachenko</surname><given-names initials="Y">Yana</given-names></name><aff>
<institution>Department of Surgical Sciences, Centre for Musculoskeletal Outcomes Research, University of Otago</institution>, <addr-line>Dunedin</addr-line>, <country country="NZ">New Zealand</country></aff><xref rid="c1" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8505-8081</contrib-id><name name-style="western"><surname>Wilson</surname><given-names initials="R">Ross</given-names></name><aff>
<institution>Department of Surgical Sciences, Centre for Musculoskeletal Outcomes Research, University of Otago</institution>, <addr-line>Dunedin</addr-line>, <country country="NZ">New Zealand</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6468-7284</contrib-id><name name-style="western"><surname>Abbott</surname><given-names initials="JH">John Haxby</given-names></name><aff>
<institution>Department of Surgical Sciences, Centre for Musculoskeletal Outcomes Research, University of Otago</institution>, <addr-line>Dunedin</addr-line>, <country country="NZ">New Zealand</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9708-5308</contrib-id><name name-style="western"><surname>Dowsey</surname><given-names initials="M">Michelle</given-names></name><aff>
<institution>Department of Surgery, St Vincent&#8217;s Hospital, University of Melbourne</institution>, <addr-line>Melbourne</addr-line>, <country country="AU">Australia</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3522-7374</contrib-id><name name-style="western"><surname>Choong</surname><given-names initials="P">Peter</given-names></name><aff>
<institution>Department of Surgery, St Vincent&#8217;s Hospital, University of Melbourne</institution>, <addr-line>Melbourne</addr-line>, <country country="AU">Australia</country></aff></contrib></contrib-group><author-notes><corresp id="c1">Corresponding author: Department of Surgical Sciences, Centre for Musculoskeletal Outcomes Research, University of Otago, 201 Great King Street, Dunedin 9016, New Zealand. Email: <email>yana.pryymachenko@otago.ac.nz</email></corresp></author-notes><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><pub-date pub-type="epub" iso-8601-date="2023-12-05"><day>05</day><month>12</month><year>2023</year></pub-date><volume>41</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">476940</issue-id><fpage>916</fpage><lpage>924</lpage><pub-history><event event-type="pmc-release"><date><day>05</day><month>12</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>13</day><month>12</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-12-17 14:25:13.860"><day>17</day><month>12</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023. Published by Oxford University Press.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="cmad112.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cmad112.pdf"/><abstract><title>Abstract</title><sec id="s1"><title>Background</title><p>Opioids are commonly used both before and after total joint arthroplasty (TJA).</p></sec><sec id="s2"><title>Objective</title><p>The objective of this study was to estimate the long-term effects of pre- and perioperative opioid use in patients undergoing TJA.</p></sec><sec id="s3"><title>Methods</title><p>We used linked population datasets to identify all (<italic toggle="yes">n</italic> =18,666) patients who had a publicly funded TJA in New Zealand between 2011 and 2013. We used propensity score matching to match individuals who used opioids either before surgery, during hospital stay, or immediately post-discharge with individuals who did not based on a comprehensive set of covariates. Regression analysis was used to estimate the effect of opioid use on health and socio-economic outcomes over 5 years.</p></sec><sec id="s4"><title>Results</title><p>Opioid use in the 3 months prior to surgery was associated with significant increases in healthcare utilization and costs (number of hospitalizations 6%, days spent in hospital 14.4%, opioid scripts dispensed 181%, and total healthcare costs 11%). Also increased were the rate of receiving social benefits (2 percentage points) and the rates of opioid overdose (0.5 percentage points) and mortality (3 percentage points). Opioid use during hospital stay or post-discharge was associated with increased long-term opioid use, but there was little evidence of other adverse effects.</p></sec><sec id="s5"><title>Conclusions</title><p>Opioid use before TJA is associated with significant negative health and economic consequences and should be limited. This has implications for opioid prescribing in primary care. There is little evidence that peri- or post-operative opioid use is associated with significant long-term detriments.</p></sec></abstract><kwd-group><kwd>opioids</kwd><kwd>joint replacement</kwd><kwd>osteoarthritis</kwd><kwd>cohort analysis</kwd><kwd>propensity score</kwd><kwd>New Zealand</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source><institution-wrap><institution>Lottery Health Research</institution><institution-id institution-id-type="DOI">10.13039/501100009477</institution-id></institution-wrap></funding-source><award-id>2021-152330</award-id></award-group></funding-group><counts><page-count count="9"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text position="float" orientation="portrait"><caption><title>Key messages</title></caption><list list-type="bullet"><list-item><p>Opioid use before total joint arthroplasty is associated with long-term effects</p></list-item><list-item><p>Strongest association for healthcare utilization and costs 5 years after surgery</p></list-item><list-item><p>No association for peri- or post-operative opioid use</p></list-item><list-item><p>Little difference among subgroups (ethnicity, sex, age, income)</p></list-item></list></boxed-text><sec id="s6"><title>Introduction</title><p>Use of opioid medications for chronic pain associated with hip and knee osteoarthritis is discouraged by clinical practice guidelines,<sup><xref rid="CIT0001" ref-type="bibr">1&#8211;3</xref></sup> but remains common.<sup><xref rid="CIT0004" ref-type="bibr">4&#8211;6</xref></sup> Patients undergoing or awaiting total joint arthroplasty (TJA) for late-stage osteoarthritis typically have moderate to severe pain not adequately relieved by conservative treatments, and are therefore at higher risk of opioid prescribing.<sup><xref rid="CIT0005" ref-type="bibr">5</xref>,<xref rid="CIT0007" ref-type="bibr">7</xref></sup> It has been reported that pre- and perioperative opioid use is associated with reduced pain relief following surgery and increased risk of surgical complications, early revision,<sup><xref rid="CIT0008" ref-type="bibr">8&#8211;10</xref></sup> and persistent post-operative opioid use (3&#8211;12 months after surgery),<sup><xref rid="CIT0004" ref-type="bibr">4</xref>,<xref rid="CIT0008" ref-type="bibr">8</xref>,<xref rid="CIT0011" ref-type="bibr">11</xref>,<xref rid="CIT0012" ref-type="bibr">12</xref></sup> but there is little evidence regarding any longer-term impacts of pre- and perioperative opioid use.</p><p>Preoperative opioid prescribing may also have negative socioeconomic impacts. Some evidence suggests that preoperative opioid use is an influencing factor in lower return-to-work rates post-surgery.<sup><xref rid="CIT0013" ref-type="bibr">13&#8211;16</xref></sup> However, no studies to date have looked at broader economic, social, and healthcare outcomes following pre- and perioperative opioid use around TJA.</p><p>This paper examines the medium- to long-term health, economic, and social outcomes of pre- and perioperative opioid use in patients undergoing total hip and knee arthroplasty. Specifically, we aim to identify whether pre-operative opioid use (within 3 months prior to TJA), peri-operative use (in hospital following TJA), and immediate post-operative use (post-discharge, within 30 days of TJA) are associated with increased healthcare consumption, increased risk of adverse events, and worse socioeconomic outcomes over 5 years post-TJA. We make use of comprehensive linked national population datasets, providing a complete record of all TJAs performed in the New Zealand (NZ) public healthcare system and allowing for long-term follow-up and inclusion of a wide range of health and socioeconomic outcomes; and a propensity score matching approach using a large set of covariates to minimize potential confounding and support causal interpretation of our estimated effects.</p></sec><sec sec-type="materials" id="s7"><title>Methods</title><sec id="s8"><title>Study cohort</title><p>The study cohort consists of all individuals who underwent publicly funded knee or hip arthroplasty in NZ (accounting for about 70% of all TJAs in NZ<sup><xref rid="CIT0017" ref-type="bibr">17</xref></sup>) between June 2011 and December 2013 (to allow for a 5-year follow-up). We excluded individuals not residing in NZ throughout the one year before surgery (to facilitate complete identification of opioid use and baseline covariates); and those having TJA on another joint within 5 years of the index procedure (to avoid confounding post-surgery outcomes with those related to a subsequent surgery).</p><p>TJAs were identified using the Australian Refined-Diagnosis Related Groups classification, versions 6.0-7.0 (knee arthroplasty: I04A, I04B; hip arthroplasty: I03A, I03B). Opioid analgesics were identified from the NZ Pharmaceutical Management Agency (PHARMAC) Therapeutic Group Reference table, corresponding to ATC code N02A (Opioid Analgesics).</p></sec><sec id="s9"><title>Data sources</title><p>We used data from the Integrated Data Infrastructure (IDI), a linked research database maintained by Statistics NZ containing individual-level data covering the entire NZ population from government administrative datasets, Statistics NZ surveys, and non-governmental organizations.<sup><xref rid="CIT0018" ref-type="bibr">18</xref></sup> We used Ministry of Health hospital discharge records to identify all patients undergoing TJA in the public healthcare system and pharmaceutical dispensing records to measure opioid medication use before and after surgery. See the <xref rid="sup1" ref-type="supplementary-material">Supplementary Appendix</xref> for details of the datasets used to calculate covariates and outcomes.</p></sec><sec id="s10"><title>Treatment measures</title><p>We performed a separate analysis for each of the following treatment variables (each compared to their respective matched control groups without opioid dispensing over the corresponding period):</p><list list-type="simple"><list-item><p>1 Pre-surgery opioid use, defined as being dispensed opioid medications at least once during the 3 months before surgery (<bold><italic toggle="yes">preoperative use</italic></bold>);</p></list-item><list-item><p>2 Opioid use during hospital stay, excluding intraoperative use (at least one dispensing) (<bold><italic toggle="yes">perioperative use</italic></bold>); and</p></list-item><list-item><p>3 Post-discharge opioid use within 30 days of surgery (at least one dispensing) (<bold><italic toggle="yes">post-discharge use</italic></bold>).</p></list-item></list><p>As these analyses were conducted independently, an individual could be in the treatment (opioid use) group in none, one, or more than one of the separate analyses.</p></sec><sec id="s11"><title>Outcomes</title><p>Multiple outcomes were considered to provide a comprehensive perspective on the potential impacts of preoperative, perioperative, and post-discharge opioid use (<xref rid="B1" ref-type="boxed-text">Box 1</xref>). In the primary analysis the outcomes were measured over a period of 5 years from the end of the baseline opioid use period (the day before surgery for preoperative use analysis, the day of discharge for perioperative use, and 30 days after surgery for post-discharge use). We also conducted trajectory analysis for some (of the more common) outcomes, which were measured during each of the 60 months of the 5-year period. Details and data sources for each of the outcomes analysed are presented in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table A.1</xref>.</p><boxed-text id="B1" position="float" orientation="portrait"><caption><title>Box 1: Outcome measures analysed</title></caption><sec id="s12"><title>Healthcare utilization</title><list list-type="bullet"><list-item><p>Number of hospital admissions</p></list-item><list-item><p>Days spent in hospital</p></list-item><list-item><p>Number of emergency department visits</p></list-item><list-item><p>Number of prescriptions dispensed</p></list-item><list-item><p>Number of opioid prescriptions dispensed</p></list-item><list-item><p>Opioid use (morphine equivalent daily average dose)</p></list-item></list></sec><sec id="s13"><title>Healthcare costs</title><list list-type="bullet"><list-item><p>Total public healthcare costs</p></list-item><list-item><p>Hospitalization costs</p></list-item><list-item><p>Outpatient and emergency department costs</p></list-item><list-item><p>Pharmaceutical costs</p></list-item><list-item><p>Laboratory testing costs</p></list-item><list-item><p>Accident and injury compensation costs</p></list-item></list></sec><sec id="s14"><title>Socioeconomic outcomes</title><list list-type="bullet"><list-item><p>Total income</p></list-item><list-item><p>Income from salary and wages</p></list-item><list-item><p>Number of months in employment</p></list-item><list-item><p>Receipt of any social welfare benefits</p></list-item><list-item><p>Number of months receiving social welfare benefits</p></list-item><list-item><p>Any criminal convictions</p></list-item></list></sec><sec id="s15"><title>Incidence of adverse events and health conditions</title><list list-type="bullet"><list-item><p>TJA revision surgery</p></list-item><list-item><p>Death</p></list-item><list-item><p>Injury insurance claims (motor vehicle accident, other injury)</p></list-item><list-item><p>Opioid overdose</p></list-item><list-item><p>Constipation</p></list-item><list-item><p>Bowel obstruction</p></list-item><list-item><p>Fracture</p></list-item><list-item><p>Fall</p></list-item><list-item><p>Myocardial infarction</p></list-item><list-item><p>Heart failure</p></list-item></list></sec></boxed-text></sec><sec id="s16"><title>Covariates</title><p>Use of the comprehensive linked population datasets allowed us to control for a wide range of important covariates that are potentially associated with pre- or perioperative opioid use as well as the outcomes.<sup><xref rid="CIT0011" ref-type="bibr">11</xref></sup> The covariates included demographic and geographic characteristics, prior health service use, socioeconomic variables, surgery characteristics, and comorbid health conditions. For analysis of perioperative and post-discharge opioid use, preoperative use was included as a covariate; for analysis of post-discharge opioid use, perioperative opioid use was also included as a covariate. The full details on the covariates used and their construction can be found in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table A.3</xref>.</p></sec><sec id="s17"><title>Matching</title><p>The matching process and results have been described previously.<sup><xref rid="CIT0019" ref-type="bibr">19</xref></sup> In brief, matching was performed separately for each treatment of interest, using a combination of exact matching on key variables (sex, M&#257;ori ethnicity [NZ&#8217;s indigenous population], year of surgery, and type of surgery) and propensity score matching on all remaining covariates, using 1:1 nearest neighbour matching with replacement. The matching process yielded excellent balance on all covariates (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table A.4</xref>), with no unmatched treatment observations for the perioperative and post-discharge use groups, and &lt;0.5% unmatched for the preoperative use group.</p></sec><sec id="s18"><title>Outcome analysis</title><p>For our primary analysis, we used a linear regression model where we regressed the outcome of interest (measured over a 5-year period) on the treatment variable and covariates. The regressions were adjusted for baseline covariates and the pre-treatment measure of the outcome. As matching with replacement was used for all 3 treatment variables, weighted regression was used to obtain appropriate estimates of the average treatment effect. Confidence intervals, at the 95% confidence level, were calculated using cluster-robust standard errors to account for the matched pairs generated by the matching process.<sup><xref rid="CIT0020" ref-type="bibr">20</xref></sup> In addition, we analysed the trajectory of key outcomes over the follow-up period by regressing the outcome of interest (measured during each month of the 5-year period) on the month and the interaction between the month and the treatment status.</p><p>Separate sub-group analyses were conducted by ethnicity (M&#257;ori and non-M&#257;ori patients), type of surgery (hip and knee arthroplasty) and sex to investigate between-group differences.</p></sec><sec id="s19"><title>Sensitivity analysis</title><p>To check the robustness of our results to model specification, we estimated the regressions using no covariates and using all of the covariates included in the matching process. Because the matching process should result in a close balance of covariates between the treatment and control groups, the results should not be sensitive to the specification of regression model.<sup><xref rid="CIT0021" ref-type="bibr">21</xref></sup> Second, we checked whether the results are sensitive to the choice of estimation model. We estimated the results using Poisson regression for continuous outcomes and using logistic regression for binary outcomes. Finally, we performed the analysis for post-discharge use analysis using an alternative matching model (which sets a calliper of 0.25 SD of the propensity score; this model yielded better balance but resulted in 1% unmatched treatment observations (see the matching report<sup><xref rid="CIT0019" ref-type="bibr">19</xref></sup>)).</p></sec><sec id="s20"><title>Software</title><p>The analyses were undertaken in R (version 3.6) in the Statistics NZ IDI data lab.<sup><xref rid="CIT0022" ref-type="bibr">22</xref></sup> The R package MatchIt<sup><xref rid="CIT0023" ref-type="bibr">23</xref></sup> was used to perform the matching procedure.</p><p>The statistical analysis plan was pre-specified and published on the Open Science Framework<sup><xref rid="CIT0024" ref-type="bibr">24</xref></sup>, and the results of the matching process were published prior to conducting the outcome analysis.<sup><xref rid="CIT0019" ref-type="bibr">19</xref></sup></p></sec></sec><sec id="s21"><title>Results</title><sec id="s22"><title>Characteristics of the study cohort</title><p>We identified 18,666 individuals with TJA during the study period, of whom 6,702 (36%) were dispensed opioids in the preoperative period, 8,967 (48%) in the perioperative period, and 7,812 (42%) in the post-discharge period. After matching, the treatment groups consisted of 6,702 individuals with preoperative opioid use, 8,967 individuals with perioperative use, and 7,812 with post-discharge use (with the same number of individuals in the respective control groups). <xref rid="T1" ref-type="table">Table 1</xref> describes the baseline characteristics of the treatment and control cohorts after matching.</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1.</label><caption><p>Baseline characteristics of individuals undergoing total joint arthroplasty in New Zealand (2011&#8211;2013), after matching (means (SD) unless stated otherwise).</p></caption><table frame="hsides" rules="groups" width="100%" border="1"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="left" colspan="4" rowspan="1">Preoperative opioid use</th><th align="left" colspan="4" rowspan="1">Perioperative opioid use</th><th align="left" colspan="4" rowspan="1">Post-discharge opioid use</th></tr><tr><th align="left" rowspan="2" colspan="1">Observations, <italic toggle="yes">n</italic></th><th align="left" colspan="2" rowspan="1">Treatment</th><th align="left" colspan="2" rowspan="1">Control</th><th align="left" colspan="2" rowspan="1">Treatment</th><th align="left" colspan="2" rowspan="1">Control</th><th align="left" colspan="2" rowspan="1">Treatment</th><th align="left" colspan="2" rowspan="1">Control</th></tr><tr><th align="left" rowspan="1" colspan="1">6,702</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">6,702</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">8,967</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">8,967</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">7,812</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">7,812</th><th align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Demographic characteristics and geography</bold>
</td><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="2" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Age at surgery, years</td><td align="left" rowspan="1" colspan="1">69.4</td><td align="left" rowspan="1" colspan="1">(11.9)</td><td align="left" rowspan="1" colspan="1">70.1</td><td align="left" rowspan="1" colspan="1">(11.2)</td><td align="left" rowspan="1" colspan="1">67.7</td><td align="left" rowspan="1" colspan="1">(11.1)</td><td align="left" rowspan="1" colspan="1">67.8</td><td align="left" rowspan="1" colspan="1">(11.5)</td><td align="left" rowspan="1" colspan="1">69.5</td><td align="left" rowspan="1" colspan="1">(11.6)</td><td align="left" rowspan="1" colspan="1">69.1</td><td align="left" rowspan="1" colspan="1">(11.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Female, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">4,014</td><td align="left" rowspan="1" colspan="1">(59.9)</td><td align="left" rowspan="1" colspan="1">4,014</td><td align="left" rowspan="1" colspan="1">(59.8)</td><td align="left" rowspan="1" colspan="1">4,836</td><td align="left" rowspan="1" colspan="1">(53.9)</td><td align="left" rowspan="1" colspan="1">4,836</td><td align="left" rowspan="1" colspan="1">(53.9)</td><td align="left" rowspan="1" colspan="1">4,350</td><td align="left" rowspan="1" colspan="1">(55.7)</td><td align="left" rowspan="1" colspan="1">4,350</td><td align="left" rowspan="1" colspan="1">(55.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;M&#257;ori, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">690</td><td align="left" rowspan="1" colspan="1">(10.3)</td><td align="left" rowspan="1" colspan="1">690</td><td align="left" rowspan="1" colspan="1">(10.3)</td><td align="left" rowspan="1" colspan="1">918</td><td align="left" rowspan="1" colspan="1">(10.2)</td><td align="left" rowspan="1" colspan="1">918</td><td align="left" rowspan="1" colspan="1">(10.2)</td><td align="left" rowspan="1" colspan="1">834</td><td align="left" rowspan="1" colspan="1">(10.7)</td><td align="left" rowspan="1" colspan="1">834</td><td align="left" rowspan="1" colspan="1">(10.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Urban residence, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">5,655</td><td align="left" rowspan="1" colspan="1">(84.3)</td><td align="left" rowspan="1" colspan="1">5,775</td><td align="left" rowspan="1" colspan="1">(86.2)</td><td align="left" rowspan="1" colspan="1">7,461</td><td align="left" rowspan="1" colspan="1">(83.2)</td><td align="left" rowspan="1" colspan="1">7,455</td><td align="left" rowspan="1" colspan="1">(83.1)</td><td align="left" rowspan="1" colspan="1">6,588</td><td align="left" rowspan="1" colspan="1">(84.4)</td><td align="left" rowspan="1" colspan="1">6,573</td><td align="left" rowspan="1" colspan="1">(84.1)</td></tr><tr><td align="left" colspan="2" rowspan="1">
<bold>Health service use (prior to the treatment period)</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Number of hospitalizations</td><td align="left" rowspan="1" colspan="1">0.57</td><td align="left" rowspan="1" colspan="1">(1.2)</td><td align="left" rowspan="1" colspan="1">0.53</td><td align="left" rowspan="1" colspan="1">(0.9)</td><td align="left" rowspan="1" colspan="1">0.53</td><td align="left" rowspan="1" colspan="1">(1.2)</td><td align="left" rowspan="1" colspan="1">0.51</td><td align="left" rowspan="1" colspan="1">(1.0)</td><td align="left" rowspan="1" colspan="1">0.66</td><td align="left" rowspan="1" colspan="1">(1.4)</td><td align="left" rowspan="1" colspan="1">0.64</td><td align="left" rowspan="1" colspan="1">(1.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Number of emergency department visits</td><td align="left" rowspan="1" colspan="1">0.44</td><td align="left" rowspan="1" colspan="1">(1.1)</td><td align="left" rowspan="1" colspan="1">0.46</td><td align="left" rowspan="1" colspan="1">(1.1)</td><td align="left" rowspan="1" colspan="1">0.38</td><td align="left" rowspan="1" colspan="1">(1.0)</td><td align="left" rowspan="1" colspan="1">0.34</td><td align="left" rowspan="1" colspan="1">(0.9)</td><td align="left" rowspan="1" colspan="1">0.51</td><td align="left" rowspan="1" colspan="1">(1.2)</td><td align="left" rowspan="1" colspan="1">0.45</td><td align="left" rowspan="1" colspan="1">(1.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Number of prescriptions dispensed (incl. opioids)</td><td align="left" rowspan="1" colspan="1">54.9</td><td align="left" rowspan="1" colspan="1">(83.1)</td><td align="left" rowspan="1" colspan="1">46.57</td><td align="left" rowspan="1" colspan="1">(56.7)</td><td align="left" rowspan="1" colspan="1">49.23</td><td align="left" rowspan="1" colspan="1">(91.5)</td><td align="left" rowspan="1" colspan="1">47.67</td><td align="left" rowspan="1" colspan="1">(68.7)</td><td align="left" rowspan="1" colspan="1">65.65</td><td align="left" rowspan="1" colspan="1">(104.8)</td><td align="left" rowspan="1" colspan="1">62.97</td><td align="left" rowspan="1" colspan="1">(87.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Opioid prescriptions in mg of OMEDD</td><td align="left" rowspan="1" colspan="1">13.8</td><td align="left" rowspan="1" colspan="1">(42.4)</td><td align="left" rowspan="1" colspan="1">7.73</td><td align="left" rowspan="1" colspan="1">(17.3)</td><td align="left" rowspan="1" colspan="1">7.04</td><td align="left" rowspan="1" colspan="1">(29.9)</td><td align="left" rowspan="1" colspan="1">7.35</td><td align="left" rowspan="1" colspan="1">(43.0)</td><td align="left" rowspan="1" colspan="1">10.81</td><td align="left" rowspan="1" colspan="1">(40.0)</td><td align="left" rowspan="1" colspan="1">6.90</td><td align="left" rowspan="1" colspan="1">(19.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Healthcare costs (total), NZD</td><td align="left" rowspan="1" colspan="1">6,599</td><td align="left" rowspan="1" colspan="1">(15 169)</td><td align="left" rowspan="1" colspan="1">6,227</td><td align="left" rowspan="1" colspan="1">(12 607)</td><td align="left" rowspan="1" colspan="1">6,134</td><td align="left" rowspan="1" colspan="1">(13 879)</td><td align="left" rowspan="1" colspan="1">5,936</td><td align="left" rowspan="1" colspan="1">(11 607)</td><td align="left" rowspan="1" colspan="1">7,725</td><td align="left" rowspan="1" colspan="1">(16 870)</td><td align="left" rowspan="1" colspan="1">7,508</td><td align="left" rowspan="1" colspan="1">(14 328)</td></tr><tr><td align="left" colspan="2" rowspan="1">
<bold>Socio-economic variables (prior to the treatment period)</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Total income, 1,000 NZD</td><td align="left" rowspan="1" colspan="1">16.4</td><td align="left" rowspan="1" colspan="1">(15.0)</td><td align="left" rowspan="1" colspan="1">15.65</td><td align="left" rowspan="1" colspan="1">(15.3)</td><td align="left" rowspan="1" colspan="1">23.96</td><td align="left" rowspan="1" colspan="1">(25.9)</td><td align="left" rowspan="1" colspan="1">22.99</td><td align="left" rowspan="1" colspan="1">(22.0)</td><td align="left" rowspan="1" colspan="1">21.85</td><td align="left" rowspan="1" colspan="1">(21.0)</td><td align="left" rowspan="1" colspan="1">21.74</td><td align="left" rowspan="1" colspan="1">(21.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Number of months in employment, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">1,815</td><td align="left" rowspan="1" colspan="1">(27.1)</td><td align="left" rowspan="1" colspan="1">1,674</td><td align="left" rowspan="1" colspan="1">(25.0)</td><td align="left" rowspan="1" colspan="1">2,904</td><td align="left" rowspan="1" colspan="1">(32.4)</td><td align="left" rowspan="1" colspan="1">2,784</td><td align="left" rowspan="1" colspan="1">(31.0)</td><td align="left" rowspan="1" colspan="1">2,046</td><td align="left" rowspan="1" colspan="1">(26.2)</td><td align="left" rowspan="1" colspan="1">2,097</td><td align="left" rowspan="1" colspan="1">(26.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Received social benefits, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">783</td><td align="left" rowspan="1" colspan="1">(11.7)</td><td align="left" rowspan="1" colspan="1">741</td><td align="left" rowspan="1" colspan="1">(11.1)</td><td align="left" rowspan="1" colspan="1">972</td><td align="left" rowspan="1" colspan="1">(10.8)</td><td align="left" rowspan="1" colspan="1">1,092</td><td align="left" rowspan="1" colspan="1">(12.2)</td><td align="left" rowspan="1" colspan="1">960</td><td align="left" rowspan="1" colspan="1">(12.3)</td><td align="left" rowspan="1" colspan="1">927</td><td align="left" rowspan="1" colspan="1">(11.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Education (&#8220;No qualification&#8221; baseline), <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">2,124</td><td align="left" rowspan="1" colspan="1">(31.7)</td><td align="left" rowspan="1" colspan="1">2,163</td><td align="left" rowspan="1" colspan="1">(32.3)</td><td align="left" rowspan="1" colspan="1">2,814</td><td align="left" rowspan="1" colspan="1">(31.4)</td><td align="left" rowspan="1" colspan="1">2,943</td><td align="left" rowspan="1" colspan="1">(32.8)</td><td align="left" rowspan="1" colspan="1">2,472</td><td align="left" rowspan="1" colspan="1">(31.7)</td><td align="left" rowspan="1" colspan="1">2,547</td><td align="left" rowspan="1" colspan="1">(32.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Secondary school</td><td align="left" rowspan="1" colspan="1">1,485</td><td align="left" rowspan="1" colspan="1">(22.1)</td><td align="left" rowspan="1" colspan="1">1,476</td><td align="left" rowspan="1" colspan="1">(22.0)</td><td align="left" rowspan="1" colspan="1">2,061</td><td align="left" rowspan="1" colspan="1">(23.0)</td><td align="left" rowspan="1" colspan="1">2,016</td><td align="left" rowspan="1" colspan="1">(22.5)</td><td align="left" rowspan="1" colspan="1">1,716</td><td align="left" rowspan="1" colspan="1">(22.0)</td><td align="left" rowspan="1" colspan="1">1,713</td><td align="left" rowspan="1" colspan="1">(21.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Post-secondary education</td><td align="left" rowspan="1" colspan="1">1,206</td><td align="left" rowspan="1" colspan="1">(18.0)</td><td align="left" rowspan="1" colspan="1">1,224</td><td align="left" rowspan="1" colspan="1">(18.3)</td><td align="left" rowspan="1" colspan="1">1,758</td><td align="left" rowspan="1" colspan="1">(19.6)</td><td align="left" rowspan="1" colspan="1">1,776</td><td align="left" rowspan="1" colspan="1">(19.8)</td><td align="left" rowspan="1" colspan="1">1,425</td><td align="left" rowspan="1" colspan="1">(18.2)</td><td align="left" rowspan="1" colspan="1">1,497</td><td align="left" rowspan="1" colspan="1">(19.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Tertiary education</td><td align="left" rowspan="1" colspan="1">366</td><td align="left" rowspan="1" colspan="1">(5.5)</td><td align="left" rowspan="1" colspan="1">336</td><td align="left" rowspan="1" colspan="1">(5.0)</td><td align="left" rowspan="1" colspan="1">618</td><td align="left" rowspan="1" colspan="1">(6.9)</td><td align="left" rowspan="1" colspan="1">630</td><td align="left" rowspan="1" colspan="1">(7.0)</td><td align="left" rowspan="1" colspan="1">471</td><td align="left" rowspan="1" colspan="1">(6.0)</td><td align="left" rowspan="1" colspan="1">447</td><td align="left" rowspan="1" colspan="1">(5.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Unknown education</td><td align="left" rowspan="1" colspan="1">1,521</td><td align="left" rowspan="1" colspan="1">(22.7)</td><td align="left" rowspan="1" colspan="1">1,506</td><td align="left" rowspan="1" colspan="1">(22.5)</td><td align="left" rowspan="1" colspan="1">1,719</td><td align="left" rowspan="1" colspan="1">(19.2)</td><td align="left" rowspan="1" colspan="1">1,608</td><td align="left" rowspan="1" colspan="1">(17.9)</td><td align="left" rowspan="1" colspan="1">1,734</td><td align="left" rowspan="1" colspan="1">(22.2)</td><td align="left" rowspan="1" colspan="1">1,605</td><td align="left" rowspan="1" colspan="1">(20.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Surgery characteristics</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Length of stay, days</td><td align="left" rowspan="1" colspan="1">5.74</td><td align="left" rowspan="1" colspan="1">(4.2)</td><td align="left" rowspan="1" colspan="1">5.39</td><td align="left" rowspan="1" colspan="1">(3.3)</td><td align="left" rowspan="1" colspan="1">5.12</td><td align="left" rowspan="1" colspan="1">(3.1)</td><td align="left" rowspan="1" colspan="1">5.26</td><td align="left" rowspan="1" colspan="1">(4.5)</td><td align="left" rowspan="1" colspan="1">5.34</td><td align="left" rowspan="1" colspan="1">(2.8)</td><td align="left" rowspan="1" colspan="1">5.76</td><td align="left" rowspan="1" colspan="1">(4.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Knee surgery, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">2,373</td><td align="left" rowspan="1" colspan="1">(35.4)</td><td align="left" rowspan="1" colspan="1">2,373</td><td align="left" rowspan="1" colspan="1">(35.4)</td><td align="left" rowspan="1" colspan="1">4,446</td><td align="left" rowspan="1" colspan="1">(49.6)</td><td align="left" rowspan="1" colspan="1">4,446</td><td align="left" rowspan="1" colspan="1">(49.6)</td><td align="left" rowspan="1" colspan="1">3,999</td><td align="left" rowspan="1" colspan="1">(51.2)</td><td align="left" rowspan="1" colspan="1">3,999</td><td align="left" rowspan="1" colspan="1">(51.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Discharged to another health facility, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">984</td><td align="left" rowspan="1" colspan="1">(14.7)</td><td align="left" rowspan="1" colspan="1">945</td><td align="left" rowspan="1" colspan="1">(14.1)</td><td align="left" rowspan="1" colspan="1">222</td><td align="left" rowspan="1" colspan="1">(2.5)</td><td align="left" rowspan="1" colspan="1">1,479</td><td align="left" rowspan="1" colspan="1">(16.5)</td><td align="left" rowspan="1" colspan="1">1,191</td><td align="left" rowspan="1" colspan="1">(15.3)</td><td align="left" rowspan="1" colspan="1">1,011</td><td align="left" rowspan="1" colspan="1">(12.9)</td></tr><tr><td align="left" colspan="2" rowspan="1">
<bold>Comorbidities (prior to the treatment period)</bold>, <bold><italic toggle="yes">n</italic> (%)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Depression</td><td align="left" rowspan="1" colspan="1">2,070</td><td align="left" rowspan="1" colspan="1">(30.9)</td><td align="left" rowspan="1" colspan="1">2,142</td><td align="left" rowspan="1" colspan="1">(32.0)</td><td align="left" rowspan="1" colspan="1">2,058</td><td align="left" rowspan="1" colspan="1">(22.9)</td><td align="left" rowspan="1" colspan="1">2,100</td><td align="left" rowspan="1" colspan="1">(23.4)</td><td align="left" rowspan="1" colspan="1">2,277</td><td align="left" rowspan="1" colspan="1">(29.2)</td><td align="left" rowspan="1" colspan="1">2,214</td><td align="left" rowspan="1" colspan="1">(28.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Anxiety</td><td align="left" rowspan="1" colspan="1">516</td><td align="left" rowspan="1" colspan="1">(7.7)</td><td align="left" rowspan="1" colspan="1">531</td><td align="left" rowspan="1" colspan="1">(7.9)</td><td align="left" rowspan="1" colspan="1">579</td><td align="left" rowspan="1" colspan="1">(6.5)</td><td align="left" rowspan="1" colspan="1">573</td><td align="left" rowspan="1" colspan="1">(6.4)</td><td align="left" rowspan="1" colspan="1">630</td><td align="left" rowspan="1" colspan="1">(8.1)</td><td align="left" rowspan="1" colspan="1">576</td><td align="left" rowspan="1" colspan="1">(7.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hypertension/IHD/angina</td><td align="left" rowspan="1" colspan="1">2,832</td><td align="left" rowspan="1" colspan="1">(42.2)</td><td align="left" rowspan="1" colspan="1">2,937</td><td align="left" rowspan="1" colspan="1">(43.8)</td><td align="left" rowspan="1" colspan="1">3,678</td><td align="left" rowspan="1" colspan="1">(41.0)</td><td align="left" rowspan="1" colspan="1">3,900</td><td align="left" rowspan="1" colspan="1">(43.5)</td><td align="left" rowspan="1" colspan="1">3,639</td><td align="left" rowspan="1" colspan="1">(46.6)</td><td align="left" rowspan="1" colspan="1">3,648</td><td align="left" rowspan="1" colspan="1">(46.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hyperlipidaemia</td><td align="left" rowspan="1" colspan="1">2,553</td><td align="left" rowspan="1" colspan="1">(38.1)</td><td align="left" rowspan="1" colspan="1">2,547</td><td align="left" rowspan="1" colspan="1">(38.0)</td><td align="left" rowspan="1" colspan="1">3,288</td><td align="left" rowspan="1" colspan="1">(36.7)</td><td align="left" rowspan="1" colspan="1">3,483</td><td align="left" rowspan="1" colspan="1">(38.8)</td><td align="left" rowspan="1" colspan="1">3,204</td><td align="left" rowspan="1" colspan="1">(41.0)</td><td align="left" rowspan="1" colspan="1">3,387</td><td align="left" rowspan="1" colspan="1">(43.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Antiplatelet agents</td><td align="left" rowspan="1" colspan="1">2,487</td><td align="left" rowspan="1" colspan="1">(37.1)</td><td align="left" rowspan="1" colspan="1">2,721</td><td align="left" rowspan="1" colspan="1">(40.6)</td><td align="left" rowspan="1" colspan="1">3,117</td><td align="left" rowspan="1" colspan="1">(34.7)</td><td align="left" rowspan="1" colspan="1">3,201</td><td align="left" rowspan="1" colspan="1">(35.7)</td><td align="left" rowspan="1" colspan="1">3,144</td><td align="left" rowspan="1" colspan="1">(40.3)</td><td align="left" rowspan="1" colspan="1">3,162</td><td align="left" rowspan="1" colspan="1">(40.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Congestive heart failure</td><td align="left" rowspan="1" colspan="1">3,234</td><td align="left" rowspan="1" colspan="1">(48.2)</td><td align="left" rowspan="1" colspan="1">3,225</td><td align="left" rowspan="1" colspan="1">(48.1)</td><td align="left" rowspan="1" colspan="1">3,987</td><td align="left" rowspan="1" colspan="1">(44.4)</td><td align="left" rowspan="1" colspan="1">4,089</td><td align="left" rowspan="1" colspan="1">(45.6)</td><td align="left" rowspan="1" colspan="1">3,879</td><td align="left" rowspan="1" colspan="1">(49.7)</td><td align="left" rowspan="1" colspan="1">3,912</td><td align="left" rowspan="1" colspan="1">(50.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Diabetes</td><td align="left" rowspan="1" colspan="1">861</td><td align="left" rowspan="1" colspan="1">(12.8)</td><td align="left" rowspan="1" colspan="1">897</td><td align="left" rowspan="1" colspan="1">(13.4)</td><td align="left" rowspan="1" colspan="1">1,140</td><td align="left" rowspan="1" colspan="1">(12.7)</td><td align="left" rowspan="1" colspan="1">1,188</td><td align="left" rowspan="1" colspan="1">(13.2)</td><td align="left" rowspan="1" colspan="1">1,239</td><td align="left" rowspan="1" colspan="1">(15.9)</td><td align="left" rowspan="1" colspan="1">1,377</td><td align="left" rowspan="1" colspan="1">(17.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Gastric acid disorder</td><td align="left" rowspan="1" colspan="1">3,468</td><td align="left" rowspan="1" colspan="1">(51.7)</td><td align="left" rowspan="1" colspan="1">3,534</td><td align="left" rowspan="1" colspan="1">(52.7)</td><td align="left" rowspan="1" colspan="1">4,092</td><td align="left" rowspan="1" colspan="1">(45.6)</td><td align="left" rowspan="1" colspan="1">4,161</td><td align="left" rowspan="1" colspan="1">(46.4)</td><td align="left" rowspan="1" colspan="1">3,972</td><td align="left" rowspan="1" colspan="1">(50.9)</td><td align="left" rowspan="1" colspan="1">3,999</td><td align="left" rowspan="1" colspan="1">(51.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Liver disease</td><td align="left" rowspan="1" colspan="1">849</td><td align="left" rowspan="1" colspan="1">(12.7)</td><td align="left" rowspan="1" colspan="1">915</td><td align="left" rowspan="1" colspan="1">(13.7)</td><td align="left" rowspan="1" colspan="1">903</td><td align="left" rowspan="1" colspan="1">(10.1)</td><td align="left" rowspan="1" colspan="1">888</td><td align="left" rowspan="1" colspan="1">(9.9)</td><td align="left" rowspan="1" colspan="1">1,074</td><td align="left" rowspan="1" colspan="1">(13.8)</td><td align="left" rowspan="1" colspan="1">939</td><td align="left" rowspan="1" colspan="1">(12.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Gout</td><td align="left" rowspan="1" colspan="1">624</td><td align="left" rowspan="1" colspan="1">(9.3)</td><td align="left" rowspan="1" colspan="1">558</td><td align="left" rowspan="1" colspan="1">(8.3)</td><td align="left" rowspan="1" colspan="1">783</td><td align="left" rowspan="1" colspan="1">(8.7)</td><td align="left" rowspan="1" colspan="1">837</td><td align="left" rowspan="1" colspan="1">(9.3)</td><td align="left" rowspan="1" colspan="1">756</td><td align="left" rowspan="1" colspan="1">(9.7)</td><td align="left" rowspan="1" colspan="1">807</td><td align="left" rowspan="1" colspan="1">(10.3)</td></tr></tbody></table><table-wrap-foot><fn id="T1Fn1"><p>NZD = New Zealand dollar; OMEDD = Oral morphine equivalent daily dose.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s23"><title>Regression analysis</title><p>Use of opioids during the 3 months before surgery (preoperative use) was associated with a significant increase in hospitalizations, days spent in hospital, opioid and total pharmaceutical use, and healthcare costs over 5 years post-surgery (<xref rid="T2" ref-type="table">Table 2</xref>). It was also associated with a higher probability of death, opioid overdose, and receipt of social welfare benefits. Other socioeconomic outcomes had the expected direction of association&#8212;preoperative opioid use being associated with worse outcomes&#8212;but were not statistically significant. <xref rid="F1" ref-type="fig">Figure 1</xref> presents estimates of these associations by month (for the outcomes with significant associations in <xref rid="T2" ref-type="table">Table 2</xref>). The associations with days in hospital and total healthcare costs were highest during the first month post-surgery (which includes the impact of longer length of stay in the index (surgery) admission), after which they were evenly distributed across the period. The association with opioid use was highest during the second month post-surgery, after which it gradually declined and stabilized at half of its original size at around 24-month mark. The associations for the rest of the outcomes were approximately stable across the 5-year period.</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2.</label><caption><p>Association between opioid use and long-term outcomes of total joint arthroplasty patients in New Zealand (2011&#8211;2013).</p></caption><table frame="hsides" rules="groups" width="100%" border="1"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Outcome</th><th align="left" colspan="2" rowspan="1">Preoperative opioid use (<italic toggle="yes">n</italic> = 13,404)</th><th align="left" colspan="2" rowspan="1">Perioperative opioid use (<italic toggle="yes">n</italic> = 17,934)</th><th align="left" colspan="2" rowspan="1">Post-discharge opioid use (<italic toggle="yes">n</italic> = 15,624)</th></tr><tr><th align="left" rowspan="1" colspan="1">Est.</th><th align="left" rowspan="1" colspan="1">(95% CI)</th><th align="left" rowspan="1" colspan="1">Est.</th><th align="left" rowspan="1" colspan="1">(95% CI)</th><th align="left" rowspan="1" colspan="1">Est.</th><th align="left" rowspan="1" colspan="1">(95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="7" rowspan="1">
<bold>Healthcare utilization and healthcare costs</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Hospitalizations</td><td align="left" rowspan="1" colspan="1">0.24</td><td align="left" rowspan="1" colspan="1">(0.03 to 0.45)</td><td align="left" rowspan="1" colspan="1">&#8722;0.10</td><td align="left" rowspan="1" colspan="1">(&#8722;0.27 to 0.08)</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">(&#8722;0.18 to 0.27)</td></tr><tr><td align="left" rowspan="1" colspan="1">Days in hospital</td><td align="left" rowspan="1" colspan="1">2.41</td><td align="left" rowspan="1" colspan="1">(0.96 to 3.85)</td><td align="left" rowspan="1" colspan="1">&#8722;1.51</td><td align="left" rowspan="1" colspan="1">(&#8722;2.35 to &#8722;0.66)</td><td align="left" rowspan="1" colspan="1">&#8722;1.42</td><td align="left" rowspan="1" colspan="1">(&#8722;2.84 to &#8722;0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">Emergency department visits</td><td align="left" rowspan="1" colspan="1">0.24</td><td align="left" rowspan="1" colspan="1">(&#8722;0.01 to 0.49)</td><td align="left" rowspan="1" colspan="1">&#8722;0.06</td><td align="left" rowspan="1" colspan="1">(&#8722;0.20 to 0.08)</td><td align="left" rowspan="1" colspan="1">0.06</td><td align="left" rowspan="1" colspan="1">(&#8722;0.17 to 0.28)</td></tr><tr><td align="left" rowspan="1" colspan="1">Prescriptions dispensed</td><td align="left" rowspan="1" colspan="1">50.94</td><td align="left" rowspan="1" colspan="1">(32.15 to 69.73)</td><td align="left" rowspan="1" colspan="1">1.28</td><td align="left" rowspan="1" colspan="1">(&#8722;8.48 to 11.03)</td><td align="left" rowspan="1" colspan="1">22.05</td><td align="left" rowspan="1" colspan="1">(7.39 to 36.71)</td></tr><tr><td align="left" rowspan="1" colspan="1">Opioid prescriptions (number)</td><td align="left" rowspan="1" colspan="1">19.67</td><td align="left" rowspan="1" colspan="1">(16.85 to 22.48)</td><td align="left" rowspan="1" colspan="1">3.27</td><td align="left" rowspan="1" colspan="1">(1.29 to 5.26)</td><td align="left" rowspan="1" colspan="1">13.41</td><td align="left" rowspan="1" colspan="1">(11.02 to 15.79)</td></tr><tr><td align="left" rowspan="1" colspan="1">Opioid prescriptions (OMEDD)</td><td align="left" rowspan="1" colspan="1">5.75</td><td align="left" rowspan="1" colspan="1">(4.27 to 7.24)</td><td align="left" rowspan="1" colspan="1">0.54</td><td align="left" rowspan="1" colspan="1">(&#8722;1.18 to 2.26)</td><td align="left" rowspan="1" colspan="1">4.22</td><td align="left" rowspan="1" colspan="1">(3.19 to 5.26)</td></tr><tr><td align="left" rowspan="1" colspan="1">Healthcare costs (total)</td><td align="left" rowspan="1" colspan="1">5 602</td><td align="left" rowspan="1" colspan="1">(2 652 to 8 552)</td><td align="left" rowspan="1" colspan="1">&#8722;3 109</td><td align="left" rowspan="1" colspan="1">(&#8722;5 489 to &#8722;730)</td><td align="left" rowspan="1" colspan="1">&#8722;2 932</td><td align="left" rowspan="1" colspan="1">(&#8722;6 133 to 270)</td></tr><tr><td align="left" rowspan="1" colspan="1">Outpatient (NNPAC) costs</td><td align="left" rowspan="1" colspan="1">917.6</td><td align="left" rowspan="1" colspan="1">(206.7 to 1 629)</td><td align="left" rowspan="1" colspan="1">55.06</td><td align="left" rowspan="1" colspan="1">(&#8722;602.3 to 712.4)</td><td align="left" rowspan="1" colspan="1">&#8722;184.8</td><td align="left" rowspan="1" colspan="1">(&#8722;897.6 to 528.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lab costs</td><td align="left" rowspan="1" colspan="1">12.61</td><td align="left" rowspan="1" colspan="1">(5.06 to 20.17)</td><td align="left" rowspan="1" colspan="1">6.61</td><td align="left" rowspan="1" colspan="1">(1.71 to 11.51)</td><td align="left" rowspan="1" colspan="1">3.19</td><td align="left" rowspan="1" colspan="1">(&#8722;4.04 to 10.42)</td></tr><tr><td align="left" rowspan="1" colspan="1">Pharmaceutical costs</td><td align="left" rowspan="1" colspan="1">296.0</td><td align="left" rowspan="1" colspan="1">(&#8722;179.1 to 771.2)</td><td align="left" rowspan="1" colspan="1">&#8722;217.3</td><td align="left" rowspan="1" colspan="1">(&#8722;609.0 to 174.5)</td><td align="left" rowspan="1" colspan="1">101.6</td><td align="left" rowspan="1" colspan="1">(&#8722;473.3 to 676.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hospitalization costs</td><td align="left" rowspan="1" colspan="1">4 194</td><td align="left" rowspan="1" colspan="1">(1 504 to 6 884)</td><td align="left" rowspan="1" colspan="1">&#8722;2 903</td><td align="left" rowspan="1" colspan="1">(&#8722;4 982 to &#8722;823)</td><td align="left" rowspan="1" colspan="1">&#8722;2 756</td><td align="left" rowspan="1" colspan="1">(&#8722;5 519 to 7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Accident and injury costs</td><td align="left" rowspan="1" colspan="1">176.3</td><td align="left" rowspan="1" colspan="1">(&#8722;527.5 to 880.0)</td><td align="left" rowspan="1" colspan="1">598.2</td><td align="left" rowspan="1" colspan="1">(121.8 to 1 075)</td><td align="left" rowspan="1" colspan="1">393.4</td><td align="left" rowspan="1" colspan="1">(&#8722;190.2 to 976.9)</td></tr><tr><td align="left" colspan="7" rowspan="1">
<bold>Socio-economic outcomes</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Income (total)</td><td align="left" rowspan="1" colspan="1">&#8722;2 137</td><td align="left" rowspan="1" colspan="1">(&#8722;5 200 to 927)</td><td align="left" rowspan="1" colspan="1">1 307</td><td align="left" rowspan="1" colspan="1">(&#8722;1 722 to 4 336)</td><td align="left" rowspan="1" colspan="1">202.3</td><td align="left" rowspan="1" colspan="1">(&#8722;2 611 to 3 015)</td></tr><tr><td align="left" rowspan="1" colspan="1">Income (wage and salary)</td><td align="left" rowspan="1" colspan="1">&#8722;402.8</td><td align="left" rowspan="1" colspan="1">(&#8722;3 205 to 2 399)</td><td align="left" rowspan="1" colspan="1">&#8722;893.0</td><td align="left" rowspan="1" colspan="1">(&#8722;3 755 to 1 969)</td><td align="left" rowspan="1" colspan="1">&#8722;958.4</td><td align="left" rowspan="1" colspan="1">(&#8722;3 538 to 1 621)</td></tr><tr><td align="left" rowspan="1" colspan="1">Months on benefits</td><td align="left" rowspan="1" colspan="1">0.34</td><td align="left" rowspan="1" colspan="1">(&#8722;0.19 to 0.88)</td><td align="left" rowspan="1" colspan="1">&#8722;0.19</td><td align="left" rowspan="1" colspan="1">(&#8722;0.55 to 0.18)</td><td align="left" rowspan="1" colspan="1">0.21</td><td align="left" rowspan="1" colspan="1">(&#8722;0.22 to 0.64)</td></tr><tr><td align="left" rowspan="1" colspan="1">Months of employment</td><td align="left" rowspan="1" colspan="1">&#8722;0.33</td><td align="left" rowspan="1" colspan="1">(&#8722;1.07 to 0.41)</td><td align="left" rowspan="1" colspan="1">0.12</td><td align="left" rowspan="1" colspan="1">(&#8722;0.43 to 0.66)</td><td align="left" rowspan="1" colspan="1">&#8722;0.29</td><td align="left" rowspan="1" colspan="1">(&#8722;0.81 to 0.23)</td></tr><tr><td align="left" rowspan="1" colspan="1">Received benefits</td><td align="left" rowspan="1" colspan="1">0.02</td><td align="left" rowspan="1" colspan="1">(0.01 to 0.03)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.01 to 0.01)</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">(0.00 to 0.02)</td></tr><tr><td align="left" rowspan="1" colspan="1">Convicted</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(0.00 to 0.01)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.01 to 0.00)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(0.00 to 0.01)</td></tr><tr><td align="left" colspan="7" rowspan="1">
<bold>Incidence of adverse events/health conditions</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">TJA revision</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">(0.00 to 0.02)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.02 to 0.17)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(0.00 to 0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">Deceased</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">(0.01 to 0.06)</td><td align="left" rowspan="1" colspan="1">&#8722;0.03</td><td align="left" rowspan="1" colspan="1">(&#8722;0.001 to 0.003)</td><td align="left" rowspan="1" colspan="1">&#8722;0.01</td><td align="left" rowspan="1" colspan="1">(&#8722;0.02 to 0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">Road accident</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.01 to 0.01)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.02 to 0.00)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(0.00 to 0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">Other injuries</td><td align="left" rowspan="1" colspan="1">0.15</td><td align="left" rowspan="1" colspan="1">(&#8722;0.03 to 0.33)</td><td align="left" rowspan="1" colspan="1">0.07</td><td align="left" rowspan="1" colspan="1">(&#8722;0.01 to 0.00)</td><td align="left" rowspan="1" colspan="1">0.19</td><td align="left" rowspan="1" colspan="1">(0.06 to 0.31)</td></tr><tr><td align="left" rowspan="1" colspan="1">Overdose</td><td align="left" rowspan="1" colspan="1">0.005</td><td align="left" rowspan="1" colspan="1">(0.003 to 0.008)</td><td align="left" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">(&#8722;0.03 to 0.00)</td><td align="left" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">(&#8722;0.002 to 0.003)</td></tr><tr><td align="left" rowspan="1" colspan="1">Constipation</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.02 to 0.02)</td><td align="left" rowspan="1" colspan="1">&#8722;0.01</td><td align="left" rowspan="1" colspan="1">(&#8722;0.02 to 0.00)</td><td align="left" rowspan="1" colspan="1">&#8722;0.01</td><td align="left" rowspan="1" colspan="1">(&#8722;0.02 to 0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bowel obstruction</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.01 to 0.01)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.01 to 0.00)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(0.00 to 0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">Fracture</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.02 to 0.03)</td><td align="left" rowspan="1" colspan="1">&#8722;0.02</td><td align="left" rowspan="1" colspan="1">(&#8722;0.01 to 0.00)</td><td align="left" rowspan="1" colspan="1">&#8722;0.02</td><td align="left" rowspan="1" colspan="1">(&#8722;0.04 to &#8722;0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">Falls</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">(&#8722;0.01 to 0.04)</td><td align="left" rowspan="1" colspan="1">&#8722;0.01</td><td align="left" rowspan="1" colspan="1">(&#8722;0.02 to 0.17)</td><td align="left" rowspan="1" colspan="1">&#8722;0.01</td><td align="left" rowspan="1" colspan="1">(&#8722;0.03 to 0.00)</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial infarction</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.01 to 0.02)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.001 to 0.003)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.01 to 0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart failure</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.02 to 0.02)</td><td align="left" rowspan="1" colspan="1">&#8722;0.01</td><td align="left" rowspan="1" colspan="1">(&#8722;0.02 to 0.00)</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">(&#8722;0.02 to 0.01)</td></tr></tbody></table><table-wrap-foot><fn id="T2Fn1"><p>Each estimate represents the result from a separate regression. All regressions are adjusted for baseline covariates (age, sex, ethnicity, education level, geography, comorbidities, year of surgery, and type of surgery) and the pre-treatment value of the outcome.</p></fn><fn id="T2Fn2"><p>NNPAC = National Non-Admitted Patient Collection; OMEDD = Oral morphine equivalent daily dose; TJA = total joint arthroplasty.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="F1" orientation="portrait"><label>Fig. 1.</label><caption><p>Trajectories of effect estimates for preoperative opioid use. Note: The grey lines represent the 95% confidence intervals.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="cmad112_fig1.jpg"/></fig><p>For opioid use post-surgery, the results were somewhat mixed. Individuals taking opioids during the hospital stay (perioperative use) were dispensed more opioid prescriptions and had higher costs associated with accidents or injuries during the following 5 years than individuals not taking opioids during the hospital stay. However, they spent fewer days in hospital and had lower hospitalization costs. They were also less likely to die or have fractures. As seen in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure A.1</xref>, the associations with days in hospital and total healthcare costs were evenly distributed across the period, while the association with opioid dispensing was negative during the first month after discharge, spiked during the second month and stabilized during the next few months.</p><p>Individuals taking opioids post-discharge but within 30 days of surgery (post-discharge use) were dispensed more prescription medications (total and opioid medications) and were more likely to suffer a non-traffic accident or injury during following 5 years. They were less likely to have a fracture. The associations with both total dispensing and opioid dispensing were the highest during the first month after the post-discharge period (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure A.2</xref>).</p><p>Sensitivity analyses showed that the primary results reported in <xref rid="T2" ref-type="table">Table 2</xref> were robust to the choice of matching model, model specification, and estimation model (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables A.5&#8211;A.10</xref>).</p></sec><sec id="s24"><title>Subgroup analysis</title><p>The results by sub-groups are presented in <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables A.11&#8211;A.19</xref>. There were only minor differences between sub-groups for most outcomes.</p></sec></sec><sec id="s25"><title>Discussion</title><p>Using opioids during the 3 months prior to surgery was associated with increased hospitalizations, prescriptions, including opioid prescriptions, and healthcare costs, and with increased risk of opioid overdose and all-cause mortality, over 5-year follow-up. These findings add weight to existing guideline recommendations discouraging opioid prescribing for patients awaiting hip and knee arthroplasty.<sup><xref rid="CIT0001" ref-type="bibr">1&#8211;3</xref></sup></p><p>Several methodological strengths have allowed this study to address significant gaps in prior knowledge regarding the long-term health, social and economic impacts of opioid use around TJA. The use of a comprehensive dataset covering the entire NZ population offers several advantages. First, we were able to analyse all publicly funded TJAs conducted in NZ during 2011&#8211;2013, allowing for generalizability of the results to this population. Second, we were able to control for an extensive set of covariates, follow-up individuals for 5 years post-surgery, and analyse a large set of outcomes, which have not been possible in previous studies. We were able to use pharmaceutical dispensing as our measure of opioid use rather than prescriptions or patient recall, which are less likely to reflect actual opioid use. A significant strength of this study is the research design: our comprehensive matching technique, with excellent between-group balance achieved across a large set of potential confounders, helps support causal interpretation of our results. Importantly, as prior opioid use (before the 3-month preoperative period) was included as a baseline covariate in all analyses, our results speak specifically to the need to manage preoperative opioid use in patients awaiting TJA, independent of any existing long-term opioid use.</p><p>Our findings for preoperative opioid use are in line with previous studies demonstrating a negative relationship between opioid use before TJA and subsequent healthcare utilization (e.g. readmissions,<sup><xref rid="CIT0025" ref-type="bibr">25&#8211;31</xref></sup> emergency department visits,<sup><xref rid="CIT0026" ref-type="bibr">26</xref>,<xref rid="CIT0027" ref-type="bibr">27</xref>,<xref rid="CIT0030" ref-type="bibr">30</xref></sup> opioid use,<sup><xref rid="CIT0008" ref-type="bibr">8</xref>,<xref rid="CIT0011" ref-type="bibr">11</xref>,<xref rid="CIT0031" ref-type="bibr">31</xref></sup> opioid overdose<sup><xref rid="CIT0026" ref-type="bibr">26</xref>,<xref rid="CIT0027" ref-type="bibr">27</xref></sup>) and medical costs.<sup><xref rid="CIT0028" ref-type="bibr">28</xref>,<xref rid="CIT0029" ref-type="bibr">29</xref>,<xref rid="CIT0031" ref-type="bibr">31</xref></sup> Most of these studies, however, look at shorter-term outcomes (up to 1 year). Our study shows that these effects are long-lasting and persist even 5 years after the surgery. We have also identified a link between preoperative opioid use and higher likelihood of receiving social benefits. While this association has not been previously found for TJA, it is consistent with the association between preoperative opioid use and lower rates of return to work after surgery identified in previous studies.<sup><xref rid="CIT0013" ref-type="bibr">13&#8211;16</xref></sup></p><p>Our finding that peri- and post-operative opioid use is associated with higher opioid use long-term after the TJA confirms the findings of previous studies.<sup><xref rid="CIT0011" ref-type="bibr">11</xref>,<xref rid="CIT0032" ref-type="bibr">32</xref>,<xref rid="CIT0033" ref-type="bibr">33</xref></sup> We also found that perioperative opioid use was associated with reduced days in hospital, hospitalization costs, and risk of death; we suggest caution in interpretation as this has not been confirmed in the literature. Although there are few studies on the broader health and economic effects of opioid use during surgical stay, one study found that opioid use within 3 days after a TJA is associated with increased risk of readmissions within 90 days.<sup><xref rid="CIT0034" ref-type="bibr">34</xref></sup> Post-discharge opioid prescribing was associated with increased long-term opioid and non-opioid prescribing and higher rate of injuries, but no other negative impacts were identified.</p><sec id="s26"><title>Limitations</title><p>Our findings should be considered in light of several limitations of the study. First, our analysis only covers publicly funded surgeries, and the results may not be generalizable to privately funded surgeries. As access to publicly funded surgeries in NZ is rationed, the individuals in our analysis may generally be at a later stage of disease progression, be experiencing higher pain levels, and have a longer history of opioid use before surgery compared to individuals undergoing privately funded surgeries. Privately insured patients may have better access to postoperative care and enjoy better postoperative outcomes, although some evidence also suggests they have higher rates of peri- and postoperative opioid use.<sup><xref rid="CIT0035" ref-type="bibr">35</xref></sup> Second, our data only includes prescription drugs and does not cover the use of over-the-counter opioids (such as codeine with paracetamol). Assuming that over-the-counter opioids were used as a substitute for prescription opioids (i.e. that the proportion using opioids purchased over-the-counter is higher in patients not receiving prescription opioids), our results will underestimate the true association between opioid use and outcomes. Third, our findings for the trajectories of postoperative opioid use suggest that some patients may have relied on existing stocks of opioids rather than new dispensing in the first moth post-surgery; our post-discharge opioid use measure does not capture this use, which may bias our estimates for this period. Fourth, some of the outcomes (particularly the incidence of adverse events and health conditions) have low prevalence rates and therefore the results for these outcomes should be treated with caution. Finally, while we were able to control for an extensive set of measured baseline confounders, as this was an observational study we cannot rule out the possibility of confounding by unmeasured characteristics.</p></sec></sec><sec id="s27"><title>Conclusion</title><p>This study indicates potential substantial health, economic, and social impacts of preoperative opioid use in patients with knee or hip osteoarthritis in primary care, who later undergo TJA. Despite higher numbers of TJA patients dispensed opioid medications in the peri- and post-operative periods following TJA, compared with the pre-operative period, our results find no compelling evidence that peri- and post-operative opioid prescription after TJA in NZ is associated with significant long-term detriments to healthcare utilization and healthcare costs, socio-economic outcomes, or incidence of adverse events/health conditions, at current rates of opioid dispensing.</p><p>These results highlight the importance of efforts to minimize preoperative opioid use, and suggest these should be a higher priority than addressing peri- and post-operative opioid prescription after TJA. Although opioid prescribing guidelines are available,<sup><xref rid="CIT0036" ref-type="bibr">36&#8211;38</xref></sup> there are challenges to reducing opioid prescribing in primary care<sup><xref rid="CIT0039" ref-type="bibr">39&#8211;41</xref></sup> and currently little evidence in the published literature to guide clinicians in how to address preoperative opioid use in people undergoing TJA<sup><xref rid="CIT0012" ref-type="bibr">12</xref></sup>; this should be a priority for further research.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sup1" position="float" content-type="local-data" orientation="portrait"><label>cmad112_suppl_Supplementary_Appendix</label><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cmad112_suppl_supplementary_appendix.pdf" position="float" orientation="portrait"/></supplementary-material></sec></body><back><sec sec-type="supplementary-material" id="s28"><title>Supplementary material</title><p>Supplementary material is available at <italic toggle="yes">Family Practice</italic> online.</p></sec><sec id="s29"><title>Funding</title><p>This work was supported by funding from the H.S &amp; J.C. Anderson Charitable Trust. YP was supported by a postdoctoral fellowship grant from Lottery Health Research [2021-152330]. The funders had no involvement in study design, collection, analysis and interpretation of data, writing of the report, or the decision to submit the article for publication.</p></sec><sec id="s30"><title>Ethical approval</title><p>This study was approved by the University of Otago Human Research Ethics Committee (Health) [HD20/066].</p></sec><sec id="s31"><title>IDI disclaimer</title><p>These results are not official statistics. They have been created for research purposes from the Integrated Data Infrastructure (IDI) which is carefully managed by Stats NZ. For more information about the IDI please visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.stats.govt.nz/integrated-data/" ext-link-type="uri">https://www.stats.govt.nz/integrated-data/</ext-link>. The results are based in part on tax data supplied by Inland Revenue to Stats NZ under the Tax Administration Act 1994 for statistical purposes. Any discussion of data limitations or weaknesses is in the context of using the IDI for statistical purposes, and is not related to the data&#8217;s ability to support Inland Revenue&#8217;s core operational requirements.</p></sec><sec sec-type="COI-statement" id="s32"><title>Conflict of interest</title><p>The authors have no competing interests to declare.</p></sec><sec sec-type="data-availability" id="s33"><title>Data availability</title><p>Access to the anonymised data used in this study was provided by Statistics NZ under the security and confidentiality provisions of the Statistics Act 1975. The data used in this study are not publicly available due to the strict security provisions of the IDI. Access to the IDI may be made available by Statistics NZ to approved researchers.</p></sec><ref-list id="r1"><title>References</title><ref id="CIT0001"><label>1.</label><mixed-citation publication-type="other"><comment>American Academy of Orthopaedic Surgeons Management of Osteoarthritis of the Knee (Non-Arthroplasty) Evidence-Based Clinical Practice Guideline.</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.aaos.org/oak3cpg" ext-link-type="uri">https://www.aaos.org/oak3cpg</ext-link> (<comment>21 February 2022, date last accessed</comment>).</mixed-citation></ref><ref id="CIT0002"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bannuru</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>Osani</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Vaysbrot</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Arden</surname><given-names>NK</given-names></string-name>, <string-name name-style="western"><surname>Bennell</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Bierma-Zeinstra</surname><given-names>SMA</given-names></string-name>, <string-name name-style="western"><surname>Kraus</surname><given-names>VB</given-names></string-name>, <string-name name-style="western"><surname>Lohmander</surname><given-names>LS</given-names></string-name>, <string-name name-style="western"><surname>Abbott</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Bhandari</surname><given-names>M</given-names></string-name></person-group>, <etal>et al</etal><article-title>OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis</article-title>. <source>Osteoarthritis Cartilage</source>. <year>2019</year>:<volume>27</volume>(<issue>11</issue>):<fpage>1578</fpage>&#8211;<lpage>1589</lpage>.<pub-id pub-id-type="pmid">31278997</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.joca.2019.06.011</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kolasinski</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Neogi</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hochberg</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Oatis</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Guyatt</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Block</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Callahan</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Copenhaver</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Dodge</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Felson</surname><given-names>D</given-names></string-name></person-group>, <etal>et al</etal><article-title>2019 American College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee</article-title>. <source>Arthritis Care Res</source>. <year>2020</year>:<volume>72</volume>(<issue>2</issue>):<fpage>149</fpage>&#8211;<lpage>162</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/acr.24131</pub-id><pub-id pub-id-type="pmcid">PMC11488261</pub-id><pub-id pub-id-type="pmid">31908149</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Inacio</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Hansen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Pratt</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Graves</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Roughead</surname><given-names>EE.</given-names></string-name></person-group><article-title>Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study</article-title>. <source>BMJ Open</source>. <year>2016</year>:<volume>6</volume>(<issue>4</issue>):<fpage>e010664</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2015-010664</pub-id><pub-id pub-id-type="pmcid">PMC4853994</pub-id><pub-id pub-id-type="pmid">27130165</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wilson</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Pryymachenko</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Audas</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Abbott</surname><given-names>JH.</given-names></string-name></person-group><article-title>for the Consortium Against the overuse of Opiates in Surgery (CAOS) Long-term opioid medication use before and after joint replacement surgery in New Zealand</article-title>. <source>N Z Med J</source>. <year>2019</year>:<volume>132</volume>(<issue>1507</issue>):<fpage>33</fpage>&#8211;<lpage>47</lpage>.<pub-id pub-id-type="pmid">31830015</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Choudhry</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Franklin</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Bykov</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Eikermann</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lii</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Fischer</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Bateman</surname><given-names>BT.</given-names></string-name></person-group><article-title>Patterns and predictors of persistent opioid use following hip or knee arthroplasty</article-title>. <source>Osteoarthritis Cartilage</source>. <year>2017</year>:<volume>25</volume>(<issue>9</issue>):<fpage>1399</fpage>&#8211;<lpage>1406</lpage>.<pub-id pub-id-type="pmid">28433815</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.joca.2017.04.002</pub-id><pub-id pub-id-type="pmcid">PMC5565694</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Turppo</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Sund</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Huopio</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kr&#246;ger</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Sirola</surname><given-names>J.</given-names></string-name></person-group><article-title>Pain medication purchases before and after total hip and knee arthroplasty: a register study of 329,743 arthroplasties</article-title>. <source>Acta Orthop</source>. <year>2022</year>:<volume>93</volume>:<fpage>534</fpage>&#8211;<lpage>541</lpage>.<pub-id pub-id-type="pmid">35694789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2340/17453674.2022.2929</pub-id><pub-id pub-id-type="pmcid">PMC9189755</pub-id></mixed-citation></ref><ref id="CIT0008"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rozell</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Courtney</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Dattilo</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>CH</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>G-C.</given-names></string-name></person-group><article-title>Preoperative opioid use independently predicts narcotic consumption and complications after total joint arthroplasty</article-title>. <source>J Arthroplasty</source>. <year>2017</year>:<volume>32</volume>(<issue>9</issue>):<fpage>2658</fpage>&#8211;<lpage>2662</lpage>.<pub-id pub-id-type="pmid">28478186</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2017.04.002</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Inacio</surname><given-names>MCS</given-names></string-name>, <string-name name-style="western"><surname>Pratt</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Roughead</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Paxton</surname><given-names>EW</given-names></string-name>, <string-name name-style="western"><surname>Graves</surname><given-names>SE.</given-names></string-name></person-group><article-title>Opioid use after total hip arthroplasty surgery is associated with revision surgery</article-title>. <source>BMC Musculoskelet Disord</source>. <year>2016</year>:<volume>17</volume>:<fpage>122</fpage>.<pub-id pub-id-type="pmid">26965992</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12891-016-0970-6</pub-id><pub-id pub-id-type="pmcid">PMC4785728</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ben-Ari</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Chansky</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Rozet</surname><given-names>I.</given-names></string-name></person-group><article-title>Preoperative opioid use is associated with early revision after total knee arthroplasty: a study of male patients treated in the Veterans Affairs system</article-title>. <source>J Bone Joint Surg Am</source>. <year>2017</year>:<volume>99</volume>(<issue>1</issue>):<fpage>1</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.16.00167</pub-id><pub-id pub-id-type="pmid">28060227</pub-id></mixed-citation></ref><ref id="CIT0011"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pryymachenko</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Abbott</surname><given-names>JH</given-names></string-name></person-group>, <etal>et al</etal><article-title>Risk factors for chronic opioid use following hip and knee arthroplasty: evidence from New Zealand population data</article-title>. <source>J Arthroplasty</source>. <year>2020</year>:<volume>35</volume>(<issue>11</issue>):<fpage>3099</fpage>&#8211;<lpage>3107.e14</lpage>.<pub-id pub-id-type="pmid">32684397</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2020.06.040</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shadbolt</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Abbott</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Camacho</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Clarke</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lohmander</surname><given-names>LS</given-names></string-name>, <string-name name-style="western"><surname>Spelman</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>EC</given-names></string-name>, <string-name name-style="western"><surname>Thorlund</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Dowsey</surname><given-names>MM</given-names></string-name></person-group>, <etal>et al</etal><article-title>The surgeon&#8217;s role in the opioid crisis: a narrative review and call to action</article-title>. <source>Front Surg</source>. <year>2020</year>:<volume>7</volume>:<fpage>4</fpage>.<pub-id pub-id-type="pmid">32133370</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fsurg.2020.00004</pub-id><pub-id pub-id-type="pmcid">PMC7041404</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hah</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Shrestha</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Pirrotta</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Huddleston</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Goodman</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Amanatullah</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Dirbas</surname><given-names>FM</given-names></string-name>, <string-name name-style="western"><surname>Carroll</surname><given-names>IR</given-names></string-name>, <string-name name-style="western"><surname>Schofield</surname><given-names>D.</given-names></string-name></person-group><article-title>Return to work and productivity loss after surgery: a health economic evaluation</article-title>. <source>Int J Surg</source>. <year>2021</year>:<volume>95</volume>:<fpage>106100</fpage>.<pub-id pub-id-type="pmid">34600123</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijsu.2021.106100</pub-id><pub-id pub-id-type="pmcid">PMC8604782</pub-id></mixed-citation></ref><ref id="CIT0014"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Faour</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Haas</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Percy</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Woods</surname><given-names>ST</given-names></string-name>, <string-name name-style="western"><surname>Ahn</surname><given-names>UM</given-names></string-name>, <string-name name-style="western"><surname>Ahn</surname><given-names>NU.</given-names></string-name></person-group><article-title>Prolonged preoperative opioid therapy associated with poor return to work rates after single-level cervical fusion for radiculopathy for patients receiving workers&#8217; compensation benefits</article-title>. <source>Spine</source>. <year>2017</year>;<volume>42</volume>(<issue>2</issue>):<fpage>E104</fpage>&#8211;<lpage>E110</lpage>.<pub-id pub-id-type="pmid">27224882</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/BRS.0000000000001715</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>O&#8217;Donnell</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Haas</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Percy</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Woods</surname><given-names>ST</given-names></string-name>, <string-name name-style="western"><surname>Ahn</surname><given-names>UM</given-names></string-name>, <string-name name-style="western"><surname>Ahn</surname><given-names>NU.</given-names></string-name></person-group><article-title>Preoperative opioid use is a predictor of poor return to work in workers&#8217; compensation patients after lumbar diskectomy</article-title>. <source>Spine</source>. <year>2018</year>:<volume>43</volume>(<issue>8</issue>):<fpage>594</fpage>&#8211;<lpage>602</lpage>.<pub-id pub-id-type="pmid">28837531</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/BRS.0000000000002385</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zakaria</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Mansour</surname><given-names>TR</given-names></string-name>, <string-name name-style="western"><surname>Telemi</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Asmaro</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Bazydlo</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Schultz</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Nerenz</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Abdulhak</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Khalil</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Easton</surname><given-names>R</given-names></string-name></person-group>, <etal>et al</etal><article-title>The Association of preoperative opioid usage with patient-reported outcomes, adverse events, and return to work after lumbar fusion: analysis from the Michigan Spine Surgery Improvement Collaborative (MSSIC)</article-title>. <source>Neurosurgery</source>. <year>2020</year>:<volume>87</volume>(<issue>1</issue>):<fpage>142</fpage>&#8211;<lpage>149</lpage>.<pub-id pub-id-type="pmid">31595963</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/neuros/nyz423</pub-id></mixed-citation></ref><ref id="CIT0017"><label>17.</label><mixed-citation publication-type="book"><article-title>NZOA Joint Registry Annual Reports</article-title>. <source><italic toggle="yes">New Zealand Joint Registry Nineteen Year Report (January 1999 - December 2017)</italic></source>. <publisher-loc>Wellington, New Zealand</publisher-loc>: <publisher-name>New Zealand Orthopaedic Association</publisher-name>; <year>2018</year>.</mixed-citation></ref><ref id="CIT0018"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Milne</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Atkinson</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Blakely</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Day</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Douwes</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gibb</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Nicolson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Shackleton</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Sporle</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Teng</surname><given-names>A.</given-names></string-name></person-group><article-title>Data resource profile: the New Zealand Integrated Data Infrastructure (IDI)</article-title>. <source>Int J Epidemiol</source>. <year>2019</year>;<volume>48</volume>(<issue>3</issue>):<fpage>677</fpage>&#8211;<lpage>677e</lpage>.<pub-id pub-id-type="pmid">30793742</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyz014</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name name-style="western"><surname>Pryymachenko</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Abbott</surname><given-names>JH.</given-names></string-name></person-group><comment>The long-term impacts of opioid use before and after joint replacement surgery: Report on finding the optimal matching model</comment>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ourarchive.otago.ac.nz/handle/10523/12166" ext-link-type="uri">https://ourarchive.otago.ac.nz/handle/10523/12166</ext-link>; <year>2021</year>.</mixed-citation></ref><ref id="CIT0020"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Abadie</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Spiess</surname><given-names>J.</given-names></string-name></person-group><article-title>Robust post-matching inference</article-title>. <source>J Am Stat Assoc</source>. <year>2022</year>;<volume>117</volume>(<issue>538</issue>):<fpage>983</fpage>&#8211;<lpage>995</lpage>.</mixed-citation></ref><ref id="CIT0021"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ho</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Imai</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>King</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Stuart</surname><given-names>EA.</given-names></string-name></person-group><article-title>Matching as non-parametric preprocessing for reducing model dependence in parametric causal inference</article-title>. <source>Polit Anal</source>. <year>2007</year>;<volume>15</volume>(<issue>3</issue>):<fpage>199</fpage>&#8211;<lpage>236</lpage>.</mixed-citation></ref><ref id="CIT0022"><label>22.</label><mixed-citation publication-type="book"><collab>R Core Team</collab>. <source>R: A language and environment for statistical computing [Internet]</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>R Foundation for Statistical Computing</publisher-name>; <year>2020</year>. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.R-project.org" ext-link-type="uri">http://www.R-project.org</ext-link></mixed-citation></ref><ref id="CIT0023"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ho</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Imai</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>King</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Stuart</surname><given-names>EA.</given-names></string-name></person-group><article-title>MatchIt: nonparametric preprocessing for parametric causal inference</article-title>. <source>J Stat Softw</source>. <year>2011</year>:<volume>42</volume>(<issue>8</issue>):<fpage>1</fpage>&#8211;<lpage>28</lpage>.</mixed-citation></ref><ref id="CIT0024"><label>24.</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name name-style="western"><surname>Pryymachenko</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>R.</given-names></string-name></person-group><article-title>The long-term impacts of opioid use before and after joint replacement surgery: analysis plan</article-title>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://osf.io/kujfz/" ext-link-type="uri">https://osf.io/kujfz/</ext-link>; <year>2020</year> (<comment>8 October 2022, date last accessed</comment>).</mixed-citation></ref><ref id="CIT0025"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Weick</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Bawa</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Dirschl</surname><given-names>DR.</given-names></string-name></person-group><article-title>Luu HH preoperative opioid use is associated with higher readmission and revision rates in total knee and total hip arthroplasty</article-title>. <source>J Bone Jt Surg</source>. <year>2018</year>:<volume>100</volume>(<issue>14</issue>):<fpage>1171</fpage>&#8211;<lpage>1176</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.17.01414</pub-id><pub-id pub-id-type="pmid">30020122</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wilson</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Farley</surname><given-names>KX</given-names></string-name>, <string-name name-style="western"><surname>Bradbury</surname><given-names>TL</given-names></string-name>, <string-name name-style="western"><surname>Erens</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Guild</surname><given-names>GN.</given-names></string-name></person-group><article-title>Preoperative opioid use is a risk factor for complication and increased healthcare utilization following revision total knee arthroplasty</article-title>. <source>The Knee</source>. <year>2020</year>:<volume>27</volume>(<issue>4</issue>):<fpage>1121</fpage>&#8211;<lpage>1127</lpage>.<pub-id pub-id-type="pmid">32711872</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.knee.2020.05.013</pub-id></mixed-citation></ref><ref id="CIT0027"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wilson</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Farley</surname><given-names>KX</given-names></string-name>, <string-name name-style="western"><surname>Bradbury</surname><given-names>TL</given-names></string-name>, <string-name name-style="western"><surname>Erens</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Bradbury</surname><given-names>TL</given-names></string-name>, <string-name name-style="western"><surname>Guild</surname><given-names>GN.</given-names></string-name></person-group><article-title>Preoperative opioid use is a risk factor for complication following revision total hip arthroplasty</article-title>. <source>Hip Int</source>. <year>2022</year>;<volume>32</volume>(<issue>3</issue>):<fpage>363</fpage>&#8211;<lpage>370</lpage>.<pub-id pub-id-type="pmid">32762258</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1120700020947400</pub-id></mixed-citation></ref><ref id="CIT0028"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sodhi</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Anis</surname><given-names>HK</given-names></string-name>, <string-name name-style="western"><surname>Acu&#241;a</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Vakharia</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Piuzzi</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Higuera</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Roche</surname><given-names>MW</given-names></string-name>, <string-name name-style="western"><surname>Mont</surname><given-names>MA.</given-names></string-name></person-group><article-title>The effects of opioid use on thromboembolic complications, readmission rates, and 90-day episode of care costs after total hip arthroplasty</article-title>. <source>J Arthroplasty</source>. <year>2020</year>:<volume>35</volume>(<issue>6S</issue>):<fpage>S237</fpage>&#8211;<lpage>S240</lpage>.<pub-id pub-id-type="pmid">32197965</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2020.02.014</pub-id></mixed-citation></ref><ref id="CIT0029"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vakharia</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Sabeh</surname><given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>Vakharia</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Damodar</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Law</surname><given-names>TY</given-names></string-name>, <string-name name-style="western"><surname>Roche</surname><given-names>MW.</given-names></string-name></person-group><article-title>Comparison of implant related complications amongst patients with opioid use disorder and non-users following total knee arthroplasty</article-title>. <source>World J Orthop</source>. <year>2019</year>:<volume>10</volume>(<issue>3</issue>):<fpage>137</fpage>&#8211;<lpage>144</lpage>.<pub-id pub-id-type="pmid">30918797</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5312/wjo.v10.i3.137</pub-id><pub-id pub-id-type="pmcid">PMC6428996</pub-id></mixed-citation></ref><ref id="CIT0030"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jain</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Brock</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Malik</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Phillips</surname><given-names>FM</given-names></string-name>, <string-name name-style="western"><surname>Khan</surname><given-names>SN.</given-names></string-name></person-group><article-title>Prediction of complications, readmission, and revision surgery based on duration of preoperative opioid use: analysis of major joint replacement and lumbar fusion</article-title>. <source>J Bone Joint Surg Am</source>. <year>2019</year>:<volume>101</volume>(<issue>5</issue>):<fpage>384</fpage>&#8211;<lpage>391</lpage>.<pub-id pub-id-type="pmid">30845032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.18.00502</pub-id></mixed-citation></ref><ref id="CIT0031"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Peratikos</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Weeks</surname><given-names>HL</given-names></string-name>, <string-name name-style="western"><surname>Pisansky</surname><given-names>AJB</given-names></string-name>, <string-name name-style="western"><surname>Yong</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Stringer</surname><given-names>EA.</given-names></string-name></person-group><article-title>Effect of preoperative opioid use on adverse outcomes, medical spending, and persistent opioid use following elective total joint arthroplasty in the United States: a large retrospective cohort study of administrative claims data</article-title>. <source>Pain Med</source>. <year>2020</year>:<volume>21</volume>(<issue>3</issue>):<fpage>521</fpage>&#8211;<lpage>531</lpage>.<pub-id pub-id-type="pmid">31120529</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pm/pnz083</pub-id><pub-id pub-id-type="pmcid">PMC7060398</pub-id></mixed-citation></ref><ref id="CIT0032"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Delaney</surname><given-names>LD</given-names></string-name>, <string-name name-style="western"><surname>Gunaseelan</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Rieck</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>DupreeI</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Hallstrom</surname><given-names>BR</given-names></string-name>, <string-name name-style="western"><surname>Waljee</surname><given-names>JF.</given-names></string-name></person-group><article-title>High-risk prescribing increases rates of new persistent opioid use in total hip arthroplasty patients</article-title>. <source>J Arthroplasty</source>. <year>2020</year>:<volume>35</volume>(<issue>9</issue>):<fpage>2472</fpage>&#8211;<lpage>2479.e2</lpage>.<pub-id pub-id-type="pmid">32389404</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2020.04.019</pub-id><pub-id pub-id-type="pmcid">PMC8289485</pub-id></mixed-citation></ref><ref id="CIT0033"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>O&#8217;Brien</surname><given-names>PE</given-names></string-name>, <string-name name-style="western"><surname>Mears</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Siegel</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Barnes</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Stambough</surname><given-names>JB.</given-names></string-name></person-group><article-title>Does in-hospital opioid use affect opioid consumption after total joint arthroplasty</article-title>? <source>J Arthroplasty</source>. <year>2022</year>:<volume>37</volume>(<issue>5</issue>):<fpage>824</fpage>&#8211;<lpage>830</lpage>.<pub-id pub-id-type="pmid">35114319</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2022.01.072</pub-id></mixed-citation></ref><ref id="CIT0034"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chung</surname><given-names>BC</given-names></string-name>, <string-name name-style="western"><surname>Bouz</surname><given-names>GJ</given-names></string-name>, <string-name name-style="western"><surname>Mayfield</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>Nakata</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Christ</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Oakes</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Lieberman</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Heckmann</surname><given-names>ND.</given-names></string-name></person-group><article-title>Dose-dependent early postoperative opioid use is associated with periprosthetic joint infection and other complications in primary TJA</article-title>. <source>J Bone Joint Surg Am</source>. <year>2021</year>:<volume>103</volume>(<issue>16</issue>):<fpage>1531</fpage>&#8211;<lpage>1542</lpage>.<pub-id pub-id-type="pmid">34043598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.21.00045</pub-id></mixed-citation></ref><ref id="CIT0035"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Schumacher</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Menendez</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Pagani</surname><given-names>NR</given-names></string-name>, <string-name name-style="western"><surname>Freiberg</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Kwon</surname><given-names>YM</given-names></string-name>, <string-name name-style="western"><surname>Bedair</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ring</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rubash</surname><given-names>HE.</given-names></string-name></person-group><article-title>Variation in perioperative opioid use after total joint arthroplasty</article-title>. <source>J Orthop</source>. <year>2021</year>:<volume>25</volume>:<fpage>162</fpage>&#8211;<lpage>166</lpage>.<pub-id pub-id-type="pmid">34025059</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jor.2021.05.003</pub-id><pub-id pub-id-type="pmcid">PMC8131953</pub-id></mixed-citation></ref><ref id="CIT0036"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dowell</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Haegerich</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Chou</surname><given-names>R.</given-names></string-name></person-group><article-title>CDC guideline for prescribing opioids for chronic pain &#8211; United States</article-title>. <source>JAMA</source>. <year>2016</year>:<volume>315</volume>(<issue>15</issue>):<fpage>1624</fpage>&#8211;<lpage>1645</lpage>.<pub-id pub-id-type="pmid">26977696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2016.1464</pub-id><pub-id pub-id-type="pmcid">PMC6390846</pub-id></mixed-citation></ref><ref id="CIT0037"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dowell</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Ragan</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Baldwin</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Chou</surname><given-names>R.</given-names></string-name></person-group><article-title>CDC clinical practice guideline for prescribing opioids for pain&#8212;United States, 2022</article-title>. <source>MMWR Recomm Rep</source>. <year>2022</year>:<volume>71</volume>(<issue>RR-3</issue>):<fpage>1</fpage>&#8211;<lpage>95</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.15585/mmwr.rr7103a1</pub-id><pub-id pub-id-type="pmcid">PMC9639433</pub-id><pub-id pub-id-type="pmid">36327391</pub-id></mixed-citation></ref><ref id="CIT0038"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Langford</surname><given-names>AV</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Bero</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Blyth</surname><given-names>FM</given-names></string-name>, <string-name name-style="western"><surname>Doctor</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Holliday</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Jeon</surname><given-names>Y&#8208;H</given-names></string-name>, <string-name name-style="western"><surname>Moullin</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Murnion</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Nielsen</surname><given-names>S</given-names></string-name></person-group>, <etal>et al</etal><article-title>Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations</article-title>. <source>Med J Aust</source>. <year>2023</year>:<volume>219</volume>(<issue>2</issue>):<fpage>80</fpage>&#8211;<lpage>89</lpage>.<pub-id pub-id-type="pmid">37356051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5694/mja2.52002</pub-id></mixed-citation></ref><ref id="CIT0039"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tong</surname><given-names>ST</given-names></string-name>, <string-name name-style="western"><surname>Hochheimer</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Brooks</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Sabo</surname><given-names>RT</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Day</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Rozman</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Kashiri</surname><given-names>PL</given-names></string-name>, <string-name name-style="western"><surname>Krist</surname><given-names>AH.</given-names></string-name></person-group><article-title>Chronic opioid prescribing in primary care: factors and perspectives</article-title>. <source>Ann Fam Med</source>. <year>2019</year>:<volume>17</volume>(<issue>3</issue>):<fpage>200</fpage>&#8211;<lpage>206</lpage>.<pub-id pub-id-type="pmid">31085523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1370/afm.2357</pub-id><pub-id pub-id-type="pmcid">PMC6827634</pub-id></mixed-citation></ref><ref id="CIT0040"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lin</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Wiles</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Waller</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Goucke</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Nagree</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Gibberd</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Straker</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Maher</surname><given-names>CG</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>PPB.</given-names></string-name></person-group><article-title>What does best practice care for musculoskeletal pain look like? Eleven consistent recommendations from high-quality clinical practice guidelines: systematic review</article-title>. <source>Br J Sports Med</source>. <year>2020</year>:<volume>54</volume>(<issue>2</issue>):<fpage>79</fpage>&#8211;<lpage>86</lpage>.<pub-id pub-id-type="pmid">30826805</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bjsports-2018-099878</pub-id></mixed-citation></ref><ref id="CIT0041"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McNeilage</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Avery</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Holliday</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Glare</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ashton-James</surname><given-names>CE.</given-names></string-name></person-group><article-title>A qualitative trajectory analysis of patients&#8217; experiences tapering opioids for chronic pain</article-title>. <source>Pain</source>. <year>2022</year>;<volume>163</volume>(<issue>2</issue>):<fpage>e246</fpage>&#8211;<lpage>e260</lpage>.<pub-id pub-id-type="pmid">33990111</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/j.pain.0000000000002336</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>